These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 37600799)

  • 41. Tumor Immunology and Immunotherapy of Non-Small-Cell Lung Cancer.
    Cascone T; Fradette J; Pradhan M; Gibbons DL
    Cold Spring Harb Perspect Med; 2022 May; 12(5):. PubMed ID: 34580079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.
    Shinde A; Li R; Kim J; Salgia R; Hurria A; Amini A
    Semin Oncol; 2018 Aug; 45(4):210-219. PubMed ID: 30286944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.
    Puri S; Shafique M; Gray JE
    Curr Treat Options Oncol; 2018 Jun; 19(8):39. PubMed ID: 29931587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The new era of immune checkpoint inhibition and target therapy in early-stage non-small cell lung cancer. A review of the literature.
    Catania C; Muthusamy B; Spitaleri G; Del Signore E; Pennell NA
    Clin Lung Cancer; 2022 Mar; 23(2):108-115. PubMed ID: 34952792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A patient with metastatic non-small cell lung cancer who received pembrolizumab monotherapy after stereotactic body radiotherapy had progression-free survival of nearly 5 years: a case report.
    Ni J; Yang L; Zhu H; Chu M; Zhang C; Zhao W; Yang M; Xu X; Zheng E; Jiang X; Li R; Zhao G
    Ann Palliat Med; 2021 Apr; 10(4):4999-5009. PubMed ID: 33966436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant and Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer.
    Broderick SR
    Thorac Surg Clin; 2020 May; 30(2):215-220. PubMed ID: 32327180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoadjuvant and Adjuvant Systemic Therapy for Early-Stage Non-small-Cell Lung Cancer.
    Isaacs J; Stinchcombe TE
    Drugs; 2022 Jun; 82(8):855-863. PubMed ID: 35596880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer.
    Parekh J; Parikh K; Reuss JE; Friedlaender A; Addeo A
    Curr Oncol Rep; 2023 Aug; 25(8):913-922. PubMed ID: 37249833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients.
    Chen F; Matsuo Y; Yoshizawa A; Sato T; Sakai H; Bando T; Okubo K; Shibuya K; Date H
    J Thorac Oncol; 2010 Dec; 5(12):1999-2002. PubMed ID: 21102261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy.
    Crabtree TD; Puri V; Robinson C; Bradley J; Broderick S; Patterson GA; Liu J; Musick JF; Bell JM; Yang M; Meyers BF
    J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1183-1191; discussion 1191-2. PubMed ID: 24507980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stereotactic Body Radiation Therapy as an Alternative to Surgery in Early-Stage Non-Small-Cell Lung Cancer.
    Rosenzweig K
    Oncology (Williston Park); 2017 Jun; 31(6):492-8. PubMed ID: 28620905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of Cardiovascular Toxicity According to Tumor Laterality Among Older Patients With Early Stage Non-small Cell Lung Cancer Treated With Radiation Therapy.
    Liu BY; Rehmani S; Kale MS; Marshall D; Rosenzweig KE; Kong CY; Wisnivesky J; Sigel K
    Chest; 2022 Jun; 161(6):1666-1674. PubMed ID: 35063448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non-Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis.
    Wen SW; Han L; Lv HL; Xu YZ; Li ZH; Wang MB; Zhu YG; Su P; Tian ZQ; Zhang YF
    J Invest Surg; 2019 Jan; 32(1):27-34. PubMed ID: 28985095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives.
    Lazzari C; Spagnolo CC; Ciappina G; Di Pietro M; Squeri A; Passalacqua MI; Marchesi S; Gregorc V; Santarpia M
    Curr Oncol; 2023 Mar; 30(4):3684-3696. PubMed ID: 37185393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Shortened Radiation Time Promotes Recovery From Radiation-induced Lymphopenia in Early-Stage Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Zhao Q; Li T; Du S; He J; Zeng Z
    Technol Cancer Res Treat; 2022; 21():15330338221112287. PubMed ID: 35816375
    [No Abstract]   [Full Text] [Related]  

  • 56. Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer.
    Rajagopalan MS; Heron DE; Wegner RE; Zeh HJ; Bahary N; Krasinskas AM; Lembersky B; Brand R; Moser AJ; Quinn AE; Burton SA
    Radiat Oncol; 2013 Oct; 8():254. PubMed ID: 24175982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neoadjuvant immunotherapy in resectable non-small cell lung cancer.
    Lochrin SE; Forde PM
    Clin Adv Hematol Oncol; 2023 Aug; (8):415-423. PubMed ID: 37530615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stereotactic body radiotherapy for synchronous early stage non-small cell lung cancer.
    Steber CR; Hughes RT; Soike MH; Helis CA; Nieto K; Jacobson T; Nagatsuka M; McGinnis HS; Leyrer CM; Farris MK
    Acta Oncol; 2021 May; 60(5):605-612. PubMed ID: 33645424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sintilimab, stereotactic body radiotherapy and granulocyte-macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trial.
    Ni J; Zhou Y; Wu L; Ai X; Dong X; Chu Q; Han C; Wang X; Zhu Z
    Radiat Oncol; 2021 Sep; 16(1):177. PubMed ID: 34526044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Primer for Radiologists.
    Febbo JA; Gaddikeri RS; Shah PN
    Radiographics; 2018; 38(5):1312-1336. PubMed ID: 30074857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.